Gupta et al. [16] found that the JAK/STAT pathway is strongly activated in DLBCL patients and the cytokines involved in the activation, included interelukin-2, -6 and -10 (IL-2, IL-6 and IL-10), and epidermal growth factor (EGF). Here, IL6 is linked to diffuse large B-cell lymphoma.